Annual ROE
-655.94%
-564.98%-621.13%
December 31, 2023
Summary
- As of February 7, 2025, ATXI annual return on equity is -655.94%, with the most recent change of -564.98% (-621.13%) on December 31, 2023.
- During the last 3 years, ATXI annual ROE has fallen by -437.58% (-200.39%).
- ATXI annual ROE is now -119.21% below its all-time high of 3414.90%, reached on December 31, 2018.
Performance
ATXI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-473.61%
+275.49%+36.78%
September 30, 2024
Summary
- As of February 7, 2025, ATXI quarterly return on equity is -473.61%, with the most recent change of +275.49% (+36.78%) on September 30, 2024.
- Over the past year, ATXI quarterly ROE has dropped by -942.31% (-201.05%).
- ATXI quarterly ROE is now -129.75% below its all-time high of 1592.06%, reached on June 30, 2023.
Performance
ATXI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ATXI ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -621.1% | -201.1% |
3 y3 years | -200.4% | -71.6% |
5 y5 years | -119.2% | -121.1% |
ATXI ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -621.1% | at low | -129.8% | +56.6% |
5 y | 5-year | -621.1% | at low | -129.8% | +56.6% |
alltime | all time | -119.2% | at low | -129.8% | +56.6% |
Avenue Therapeutics ROE History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -473.61%(-36.8%) |
Jun 2024 | - | -749.10%(-219.1%) |
Mar 2024 | - | 628.81%(+34.2%) |
Dec 2023 | -655.94%(+621.1%) | 468.70%(-26.7%) |
Sep 2023 | - | 639.34%(-59.8%) |
Jun 2023 | - | 1592.06%(-245.7%) |
Mar 2023 | - | -1092.56%(+332.4%) |
Dec 2022 | -90.96%(-15.9%) | -252.68%(-35.2%) |
Sep 2022 | - | -390.02%(-6.2%) |
Jun 2022 | - | -415.93%(-5.3%) |
Mar 2022 | - | -439.43%(+59.2%) |
Dec 2021 | -108.11%(-50.5%) | -275.96%(-21.9%) |
Sep 2021 | - | -353.20%(+71.6%) |
Jun 2021 | - | -205.86%(+17.1%) |
Mar 2021 | - | -175.74%(+31.9%) |
Dec 2020 | -218.36% | -133.21%(-30.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2020 | - | -192.34%(+27.6%) |
Jun 2020 | - | -150.68%(-8.8%) |
Mar 2020 | - | -165.26%(-15.5%) |
Dec 2019 | -381.00%(-111.2%) | -195.47%(-8.7%) |
Sep 2019 | - | -214.21%(-21.2%) |
Jun 2019 | - | -272.01%(-16.6%) |
Mar 2019 | - | -326.03%(-37.5%) |
Dec 2018 | 3414.90%(-5499.1%) | -521.33%(+99.5%) |
Sep 2018 | - | -261.30%(+56.2%) |
Jun 2018 | - | -167.25%(+52.4%) |
Mar 2018 | - | -109.77%(+38.4%) |
Dec 2017 | -63.25%(-264.2%) | -79.32%(-0.7%) |
Sep 2017 | - | -79.91%(-39.8%) |
Jun 2017 | - | -132.73%(-507.9%) |
Mar 2017 | - | 32.54%(-15.5%) |
Dec 2016 | 38.52% | 38.52% |
FAQ
- What is Avenue Therapeutics annual return on equity?
- What is the all time high annual ROE for Avenue Therapeutics?
- What is Avenue Therapeutics annual ROE year-on-year change?
- What is Avenue Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Avenue Therapeutics?
- What is Avenue Therapeutics quarterly ROE year-on-year change?
What is Avenue Therapeutics annual return on equity?
The current annual ROE of ATXI is -655.94%
What is the all time high annual ROE for Avenue Therapeutics?
Avenue Therapeutics all-time high annual return on equity is 3414.90%
What is Avenue Therapeutics annual ROE year-on-year change?
Over the past year, ATXI annual return on equity has changed by -564.98% (-621.13%)
What is Avenue Therapeutics quarterly return on equity?
The current quarterly ROE of ATXI is -473.61%
What is the all time high quarterly ROE for Avenue Therapeutics?
Avenue Therapeutics all-time high quarterly return on equity is 1592.06%
What is Avenue Therapeutics quarterly ROE year-on-year change?
Over the past year, ATXI quarterly return on equity has changed by -942.31% (-201.05%)